ESH Video


September 24, 2021

6th ESH Translational Research Conference

 Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt
October 14-17, 2021 - E-Conference
REGISTRATION IS OFFERED FREE OF CHARGE as a gesture of solidarity during these difficult times.


Participants will be joining us from all over the world and from different time zones.
To make sure that everyone has access to the full scientific programme at a convenient hour,
registration will allow participants to join both
the LIVE PROGRAMME (October 14-17, 2021) and
the PROGRAMME ON DEMAND (October 4 - November 17, 2021).


The “Live Programme” will be streamed live CEST time.  It will include Meet the Expert sessions, interactive panel discussions, Q&A periods and Mentored Poster Walks. It will also include some pre-recorded lectures that will be streamed live, followed by their corresponding fully live Q&A period.

The “Programme on Demand”  will be available as of October 4, 2021. It will initially include the pre-recorded components of the scientific programme. It will be progressively enriched by the meeting’s live, interactive components which will be recorded real time during the meeting.

E-POSTERS: October 4 - November 17, 2021 The Poster Hall will also remain open until November 17, 2021. The Mentored Poster Walks scheduled in the LIVE PROGRAMME will also become available in the PROGRAMME ON DEMAND.

VIRTUAL EXHIBITION: October 4 - November 17, 2021 We invite you to visit the Exhibition area as of October 4. Our corporate partners will be pleased to welcome & chat with you.


– B-cell development and lymphomagenesis
– Genetics of malignant lymphomas and clonal evolution
– Epigenetics in malignant lymphomas
– Deregulated proteome and metabolome
– Single cell analyses, circulating tumor DNA, MRD
– Oncogenic signaling pathways
– Utilizing oncogenic signaling therapeutically
– Immunologic approaches in the treatment of lymphomas


This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.

The goals of this conference are to:
– foster scientific exchange between laboratory scientists and clinicians working on lymphoid malignancies worldwide.
– foster scientific cross-fertilization between researchers and clinicians working on different diseases with partially overlapping pathogenic mechanisms such as the B cell receptor signaling, alterations of the DNA damage response, or the increasingly important dialogue of lymphoid tumour cells with their microenvironment.
– provide opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training
A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of Lymphoid Malignancies.

Learning objectives:
Improved understanding of :
– current developments in the field of molecular pathogenesis of indolent and aggressive B-cell lymphoma including CLL
– current developments in the field of the molecular pathogenesis of T-cell lymphoma
– prognostic and predictive markers and their impact in specific clinical situations
– current treatments and future therapeutic perspectives.

For more information, click here!

With the support of*:

Premium E-Conference Partners


Diamond E-Conference Partners

Emerald E-Conference Partner

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.